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The progression of non-alcoholic fatty liver disease (NAFLD) likely involves a ‘multiple hit’
mechanism. We hypothesized that partial hepatectomy, a procedure performed frequently
in patients with NAFLD, would accelerate the progression of disease.
Methods
C57BL/6JolaHsd mice were fed a choline-deficient L-amino acid-defined diet (CD-AA) or a
choline-sufficient L-amino acid-defined control diet (CS-AA). Part of the mice in the CD-AA
group received a diet enriched in vitamin E (~20 mg /day). Two weeks after the start of the
diet, mice underwent a partial hepatectomy or a sham operation.
Results
In the CD-AA group, NAFLD activity scores were significantly higher at 7 days after partial
hepatectomy compared to the sham operated mice (3.7 ± 1.3 vs. 1.8 ± 0.7; P<0.05). In addi-
tion, TBARS, a measure for oxidative stress, in liver tissue of the CD-AA group were signifi-
cantly higher at day 1, 3 and 7 after partial hepatectomy compared to the sham operated
mice (P<0.05). Vitamin E therapy significantly reduced TBARS level at day 7 after partial
hepatectomy compared to the CD-AA diet group (P< 0.05). Vitamin E suppletion reduced
NAFLD activity score at day 7 after partial hepatectomy compared to the CD-AA group (2.3
± 0.8 vs. 3.8 ± 1.0; P<0.05).
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Conclusion
Partial hepatectomy accelerates the progression of NAFLD. Disease progression induced
by partial hepatectomy is substantially attenuated by vitamin E.
Introduction
Non-alcoholic fatty liver disease (NAFLD) is one of the most common liver disorders world-
wide [1]. NAFLD includes a disease spectrum ranging from simple steatosis to non-alcoholic
steatohepatitis (NASH), which may eventually progress to liver fibrosis and cirrhosis [2].
Mechanisms of disease progression in NAFLD are incompletely understood, but likely a “mul-
tiple-hit” model is involved [2]. In this model, the development of steatosis increases the sensi-
tivity of the liver to other hits such as oxidative stress and cytokines, leading to hepatocyte
damage and liver dysfunction [3,4]. As the number of individuals with mild to moderate liver
steatosis is increasing, it is reasonable to assume that the number of patients with steatosis that
require a partial hepatectomy is increasing [5,6].
Partial hepatectomy is performed to manage many types of malignant or benign liver
pathologies [7–9]. While a normal liver is capable to regenerate after a partial hepatectomy,
severe steatosis and NASH impair liver regeneration and increase morbidity due to post-opera-
tive complications [5,10]. In contrast, several experimental and clinical studies indicate that
mild steatosis does not impair liver regeneration [10–12]. Although the effect of steatosis on
liver regeneration has been studied extensively, the effect of partial hepatectomy on the pro-
gression of NAFLD, to our knowledge, has not yet been investigated.
Liver regeneration after partial hepatectomy is associated with the activation of inflamma-
tory signaling molecules and induction of oxidative stress [13,14]. Importantly, these factors
are important contributors to the progression of NAFLD [3,15]. We hypothesized that partial
hepatectomy would advance simple steatosis toward a progressive inflammatory phenotype
and have investigated the effect of partial hepatectomy on the progression of the NAFLD in
mice with mild steatosis. In the present study, we use a choline-deficient L-amino acid-defined
(CD-AA) diet to induce mild steatosis in mice. We confirm previous studies that showed that
mild steatosis does not impair liver regeneration. Importantly, we demonstrate that partial hep-
atectomy substantially accelerates the progression of NAFLD. In addition we show that anti-
oxidant therapy with vitamin E attenuates the post-operative progression of NAFLD.
Material and Methods
Animal studies
C57BL/6JolaHsd male mice (5–6 weeks old, Harlan Laboratories, NL) were fed either a
CD-AA diet (mouse chow 518753, Dyets Inc., PA, USA) or a CS-AA (mouse chow 518754,
Dyets Inc., PA, USA). Animals were caged in animal rooms with an alternating 12-hour light/
dark period, and had free access to food and water for the duration of the experiment. The
local Committee for Care and Use of laboratory animals of the University of Groningen
approved the experiments of this study and all the experiments were performed in accordance
with the guidelines of this Committee.
Experimental design
Two weeks after the start of the diet, mice were anesthetized using isoflurane/O2 and subjected
to a midventral laparatomy with (PHx) or without (sham) a resection of two-thirds of the liver
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choline-deficient L-amino acid-defined diet; CS-AA,
choline-sufficient L-amino acid-defined diet; TBARS,
thiobarbituric acid-reactive substances; PHx, partial
hepatectomy; H&E, hematoxylin and eosin staining;
ALT, alanine aminotransferase; AST, aspartate
aminotransferase.
volume essentially as described previously [16]. Mice remained on the CD-AA or CS-AA diet
after the partial hepatectomy or sham operation until the end of the experiment. Six mice in
each group were sacrificed at selected time points. In an independent experiment, mice were
fed the CD-AA diet for two weeks. At the end of the second week all mice were subjected to a
sham or a PHx operation. After surgery, the mice were fed the CD-AA diet or the CD-AA diet
enriched with vitamin E for one week (Vitamin E was provided in the form of DL-Alpha Toco-
pheryl Acetate with concentration of 5 mg vitamin E/gr food, mouse chow 519557, Dyets Inc.,
PA, USA). Prior to the experiment, we determined that the mice (20–25 gr) eat 4–5 grams of
CD-AA diet each day. Thus, the mice received at least 20 mg vitamin E per day by having free
access to food. We selected this dosage of vitamin E based on similar published experiments in
rats with the goal to substantially improve the antioxidant status by feeding a high dosage of
vitamin E to mice [17]. Nine mice in each group were sacrificed at day 7 after the operation.
At the time of sacrifice in all experiments, mice were weighed and anesthetized. Blood was
harvested from the inferior vena cava after the injection of an anticoagulant solution contain-
ing 3.4% sodium citrate in 0.9% saline (8 μl/g) in the inferior vena cava. The remaining liver
lobes were removed, weighed, and processed for biochemical or histological analyses.
Liver histology and immunohistochemical staining
Paraffin-embedded liver sections (5-μm thick) were stained with standard hematoxylin and
eosin (H&E) staining. These H&E sections were graded using the NAFLD scoring system [18].
At least 10 random high power fields (200X) were analyzed by two independent researchers.
The NAFLD activity score was defined as an unweighted sum of scores for liver steatosis (<5
percent = 0, 5 to 33 percent = 1,>33 to 66 percent = 2,>66 percent = 3), lobular inflammation
(no foci = 0,<2 foci per 200 X field = 1, 2 to 4 foci per 200 X field = 2,>4 foci per 200 X
field = 3) and hepatocyte ballooning (none = 0, few balloon cells = 1, many cells/prominent bal-
looning = 2) [18]. Paraffin-embedded sections were also stained using Masson’s trichrome
stain (Polysciences Inc., PA, USA) to assess presence of fibrosis. Hepatocyte proliferation was
assessed by immunohistochemical staining of ki-67 on paraffin-embedded liver sections using
a rabbit polyclonal antibody (abcam, Cambridge, UK). Proliferating hepatocytes were quanti-
fied by counting the number of nuclei positive for Ki-67, and were expressed relative to the
total nuclei stained with hematoxylin per 200X field (hepatocyte proliferation index). At least
six random high power fields were counted for each mouse.
Biochemical studies in plasma and liver tissue
Plasma levels of alanine aminotransferase (ALT) and aspartate aminotransferase (AST) were
assessed using standard biochemical methods. Thiobarbituric acid-reactive substances
(TBARS) were measured in liver homogenates as a marker for oxidative stress. Samples were
homogenized in cold 1.15% KCl buffer and TBARS were determined using malondialdehyde
as a standard as previously described [19]. Protein concentration in liver homogenates was
determined with a bicinchoninic acid (BCA) protein assay kit (Thermo Scientific, IL, USA)
using bovine serum albumin as a standard.
Real- time reverse transcriptase polymerase chain reaction
HO-1, CD68, MCP1 and NRF2 gene expressions in liver tissue of mice were determined by
real-time reverse transcriptase polymerase chain reaction (RT-PCR) as was described previ-
ously [20]. Primer sets were designed using Primer Express 2.0 software (Applied Biosystems)
and validated in a six step two-fold dilution series. For each gene the expression was
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normalized relative to the mean cycle threshold (CT) value of Beta-actin gene. Results were
finally expressed as fold induction (2[delta] CT), an index of the relative amount of mRNA
expression.
Statistical analysis
GraphPad Prism (version 5.00) was used to perform all the analyses. Results are presented as
the mean ± SD. A student t-test or a two-way analysis of variance (ANOVA) was used to deter-
mine the significance of differences between experimental groups. A P-value of less than 0.05
(P< 0.05) was considered statistically significant.
Results
The CD-AA diet induces mild steatosis in mice by 3 weeks
There are several models to induce liver steatosis in experimental animals. However, models
such as a high fat diet and ob/ob mice show minimal steatohepatitis and liver fibrosis and there-
fore are not suitable models to study the progression of NAFLD [21]. However other diet mod-
els may develop NAFLD/NASH which is more similar to human disease. In order to investigate
the effect of partial hepatectomy on the progression of NAFLD in mild steatotic livers, we used
the CD-AA diet model. The CD-AA diet induces mild steatosis by 2–3 weeks in mice. Conse-
quently, the NAFLD progresses over time and histopathological features of steatohepatitis such
as lobular inflammation, hepatocyte ballooning and fibrosis appear in the liver [22]. In accor-
dance with previous studies, the CD-AA diet induced mild steatosis by 3 weeks as was demon-
strated by histological examination (Fig 1a) and an elevated NAFLD activity score (1.8 ± 0.7).
The NAFLD activity score in the mice fed the CS-AA diet was 0 in all mice. In addition, the
liver-to-body weight ratio was significantly higher in the CD-AA group compared to the CS-AA
group (P<0.05, Fig 1b). Histological examination showed no liver fibrosis by 3 weeks in any of
the mice (data not shown). Mice in the CD-AA group had significantly higher levels of ALT and
AST in plasma compared to the CS-AA group by 3 weeks (Fig 1c and 1d, P<0.05). Altogether,
our data indicate that the mice on the CD-AA diet had mild steatosis by 3 weeks.
Mild steatosis does not impair liver regeneration after partial
hepatectomy
In order to investigate the effect of mild steatosis on the regenerative capacity of the liver, we
performed a two-thirds partial hepatectomy on the mild steatotic livers of mice on the CD-AA
diet or on the non-steatotic livers of mice on the CS-AA diet. We compared the liver mass res-
toration and hepatocyte proliferation rate at several time points after partial hepatectomy over
a period of 7 days in both of the diet groups. Liver mass restoration over time was not different
between the CD-AA and CS-AA groups (Fig 2a). The hepatocyte proliferation rate, as assessed
by ki-67 staining, was similar in both steatotic and non-steatotic livers when assessed at day 3
after the hepatectomy (Fig 2b). In addition, aminotransferase levels in plasma increased signifi-
cantly (P<0.05) after partial hepatectomy in both the CD-AA and CS-AA groups and returned
to basal levels over time (Fig 2c and 2d). Aminotransferase levels were similar in the CD-AA
and CS-AA group at all time points examined. Altogether, our data indicate that mild steatosis
does not impair liver regeneration after partial hepatectomy.
Partial hepatectomy accelerates the progression of NAFLD
To investigate the effect of a partial hepatectomy on the progression of NAFLD, we compared
the histological scores of steatotic livers of mice on a CD-AA diet at 7 days after a partial
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hepatectomy or a sham operation (Fig 3a). In the CD-AA group, the NAFLD activity scores were
significantly higher at 7 days after partial hepatectomy compared to the sham operated mice
(3.7 ± 1.3 vs. 1.8 ± 0.7; P< 0.05; Fig 3b). Liver fibrosis was not present in both sham and hepatec-
tomy groups at all the time points that were analyzed in our study (data not shown). The livers
of mice on the CS-AA diet did not have steatosis, lobular inflammation, ballooning or fibrosis at
7 days after the hepatectomy or sham operation (data not shown). Altogether, our results indi-
cate that partial hepatectomy accelerates the progression of NAFLD in mild steatotic livers.
The level of lipid peroxidation increases significantly in steatotic livers
after partial hepatectomy
Several experimental and human studies indicate that oxidative stress-mediated lipid peroxida-
tion particularly contributes to the progression of NAFLD and acts as a “second-hit” [4,23,24].
Therefore, we measured TBARS to estimate the extent of lipid peroxidation in liver
Fig 1. The choline-deficient L-amino acid-defined diet (CD-AA) inducesmild steatosis by 3 weeks. (A) Hematoxylin and eosin staining of paraffin-
embedded liver sections of mice on a CD-AA diet (right panel) and control diet (CS-AA, left panel) by 3 weeks (Magnification, X 100). (B) Liver-to-body weight
ratios of mice on a CD-AA diet or a CS-AA diet by 3 weeks (n = 9). (C) Plasma levels of ALT and (D) AST in mice on a CD-AA diet or a CS-AA diet by 3 weeks
(n = 9).
doi:10.1371/journal.pone.0143121.g001
The Effect of Partial Hepatectomy on Progression of NAFLD
PLOSONE | DOI:10.1371/journal.pone.0143121 November 24, 2015 5 / 12
homogenates at several time points after partial hepatectomy. TBARS in liver tissue of the
CD-AA group but not of the CS-AA group were significantly higher at day 1, 3 and 7 after par-
tial hepatectomy compared to the sham mice (Fig 3c, P<0.05). These data suggest that oxida-
tive stress level after partial hepatectomy increases particularly in steatotic livers.
Fig 2. Mild steatosis does not impair liver regeneration after partial hepatectomy. (A) Graph represents the restoration of liver mass over the 7-days
duration after partial hepatectomy. (B) Immunohistochemical staining of Ki-67 (yellow arrows show ki-67 positive cells) in mice on a CD-AA diet (right panel)
or a CS-AA diet (left panel) at day 3 after hepatectomy (Magnification, X 200). Graph represents the number of nuclei positive for Ki-67 relative to the total
nuclei stained with hematoxylin at day 3 after hepatectomy. At least six random high power fields were counted for each mouse. (C) Plasma levels of ALT
and (D) AST in mice on a CD-AA diet or a CS-AA diet at different time points after hepatectomy (n = 6 per time point).
doi:10.1371/journal.pone.0143121.g002
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Vitamin E therapy after partial hepatectomy significantly reduces the
oxidative stress level and attenuates the progression of NAFLD
A number of studies have suggested antioxidant therapy, particularly vitamin E, as an effective
therapy against the progression of NAFLD [17,25,26]. Therefore, in an independent experi-
ment, we treated the steatotic mice for one week after partial hepatectomy with high dosage of
vitamin E to increase the antioxidant status of the liver. We compared the histological scores of
steatotic livers of mice on a CD-AA diet and vitamin E enriched CD-AA diet at 7 days after a
partial hepatectomy or a sham operation (Fig 4a). In this independent experiment, we confirm
that partial hepatectomy accelerates disease progression in mice fed the CD-AA diet. In the
vitamin E enriched CD-AA group, the NAFLD activity scores at 7 days after partial hepatec-
tomy were significantly lower compared to the CD-AA diet group (2.3 ± 0.8 vs. 3.8 ± 1.0;
P<0.05; Fig 4b). In addition, vitamin E therapy significantly reduced the TBARS level in liver
Fig 3. Partial hepatectomy accelerates the progression of NAFLD. (A) Hematoxylin and eosin staining of paraffin embedded-liver sections of mice on a
CD-AA diet at day 7 after a partial hepatectomy (right panel) or a sham operation (left panel) (Magnification, X 200). (B) Graph represents the NAFLD activity
scores in mice on a CD-AA diet at day 7 after a partial hepatectomy or a sham operation (n = 6 per group). (C) Graph represents the TBARS levels in the liver
tissue at different time points after a partial hepatectomy (n = 6 per group) or a sham operation (n = 3 per group) in mice on CD-AA diet and CS-AA diet.
Malondialdehyde (MDA) was used as standard. * P < 0.05 for CD-AA vs. CS-AA at day 1, day 3 and day 7 after partial hepatectomy, respectively.
doi:10.1371/journal.pone.0143121.g003
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tissue at day 7 after partial hepatectomy (P<0.05, Fig 4c) without delaying the liver regenera-
tion (data not shown). We measured HO-1 (hemoxygenase -1) mRNA expression levels as a
marker for oxidative stress at 7 days after the hepatectomy in CD-AA group and CD-AA Vita-
min E group. We observed a significant decrease in HO-1 mRNA expression levels in Vitamin
E treated group compared to the control group at day 7 after hepatectomy (Fig 4d). These data
confirm our previously observed TBARS measurements.
We measured the triglyceride and cholesterol content in the liver tissue at day 7 after partial
hepatectomy in CS-AA group, CD-AA group and vitamin E enriched CD-AA group. We
observed a significant difference in the level of triglycerides and cholesterol between the
CS-AA diet group and the other two groups. The triglyceride content at day seven after partial
hepatectomy, however, was not significantly higher than sham operated mice (S1 Fig). Interest-
ingly, the cholesterol content increased after the partial hepatectomy. These findings are in
accordance with previous reports in the literature that partial hepatectomy does not affect the
triglyceride content but cholesterol synthesis increases after the partial hepatectomy [27]. Vita-
min E treatment did not affect the lipid content after partial hepatectomy. These results rein-
force the notion that the increase in NAFLD activity score following partial hepatectomy and
Fig 4. Vitamin E attenuates the progression of NAFLD after partial hepatectomy. (A) Hematoxylin and eosin staining of paraffin embedded-liver
sections of mice on a CD-AA diet (right panel) or vitamin E enriched CD-AA diet (left panel) at day 7 after a partial hepatectomy (Magnification, X 200). (B)
Graph represents the NAFLD activity scores in mice on a CD-AA diet or vitamin E enriched CD-AA diet at day 7 after a partial hepatectomy (n = 9 per group).
(C) Graph represents the TBARS levels in the liver tissue at 7 days after a partial hepatectomy or a sham operation (n = 9 per group) in mice on CD-AA diet
and vitamin E enriched CD-AA diet. Malondialdehyde (MDA) was used as standard. * P < 0.05 for CD-AA vs. vitamin E enriched CD-AA at day 7 after
operation. (D) Graph represents the mRNA expression level of hemoxygenase-1 (HO-1) in the liver tissue at day 7 after a partial hepatectomy or a sham
operation in mice on CS-AA diet (n = 6), CD-AA diet (n = 15) and vitamin E enriched CD-AA diet (n = 9). P< 0.05 for CD-AA vs Vitamin E enriched CD-AA at
day 7 after operation.
doi:10.1371/journal.pone.0143121.g004
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the inhibition of this effect by vitamin E does not reflect direct alterations of fat content of the
liver, but rather reflects effects on intrahepatic inflammatory responses. We also measured the
mRNA expression level of CD68 and MCP-1 in CD-AA group and Vitamin E enriched
CD-AA group at day 7 after partial hepatectomy. We did not observe any significant difference
in the expression levels of these markers at these time points (S1 Fig)
Altogether, in accordance with previous studies [17,25,26], our data suggests that vitamin E
acts as an antioxidant and attenuates the progression of NAFLD after partial hepatectomy.
Discussion
In this study, we report that mild liver steatosis does not impair liver regeneration in mice.
However, partial hepatectomy substantially accelerates the progression of NAFLD. In addition,
we provide evidence that enhanced oxidative stress following partial hepatectomy contributes
to the progression of NAFLD and show that antioxidant therapy with vitamin E attenuates the
progression of NAFLD.
The clinical significance of liver steatosis on liver regeneration after hepatic resection
depends upon the extent of lipid accumulation in hepatocytes and the presence of steatohepati-
tis [5,6]. Several human studies have indicated that mild steatosis does not impair liver regener-
ation [10,11]. However, in experimental models it is difficult to distinguish between the effects
of simple steatosis and the effects of a progressive phenotype of NAFLD on liver regeneration
since different models show different histopathological features of NAFLD, and rodents have
high tolerance before they display inflammatory phenotypes even in a severe steatotic status
[21]. Therefore, data emerging from experimental studies on the effect of steatosis and steato-
hepatitis on regeneration are inconsistent [12,28]. In our study, we used the CD-AA diet
model, which is suggested to be a model for simple steatosis with the ability to advance toward
steatohepatitis over time, mimicking the natural history of NAFLD/NASH in humans [22]. In
accordance with previous studies [10–12], we found that mild steatosis does not impair liver
regeneration after partial hepatectomy.
Nevertheless, the development of liver steatosis sensitizes the liver to other hits [2]. In our
study, we found that a mild steatotic phenotype could advance to a progressive inflammatory
phenotype of NAFLD after partial hepatectomy. In addition, the level of lipid peroxidation
products following partial hepatectomy was particularly higher in steatotic livers. Many experi-
mental and human studies have reported a positive association between increased levels of the
oxidative stress-mediated lipid peroxidation and the presence of progressive inflammatory
phenotypes of NAFLD [3,23,29]. Several mechanisms have been suggested for the role of oxi-
dative stress in the pathogenesis of NASH. Peroxidation of the mitochondrial/plasma mem-
brane directly leads to necrosis/apoptosis of liver cells [30]. ROS-induced Fas-ligand
expression on hepatocytes may lead to hepatocyte apoptosis given that isolated hepatocytes
from liver biopsies of NASH patients express higher levels of Fas [31]. Covalent binding of the
aldehyde products of lipid peroxidation (such as MDA) with hepatic proteins may lead to inju-
rious immune responses in the liver [3]. Activation of the NF-κB cascade by products of lipid
peroxidation can increase transcription of inflammatory cytokines and death ligands by liver
cells [32]. Although we have not studied these mechanisms, they potentially explain why an
increased level of lipid peroxidation after partial hepatectomy particularly contributes to the
progression of NAFLD following a partial hepatectomy.
These findings are important for clinical practice because they implicate that simple hepatic
steatosis, which is a benign condition and non-progressive in the majority of patients, may
advance toward a more progressive liver disease after hepatic resection. This may have adverse
clinical consequences for humans with simple steatosis that may need a partial hepatectomy
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and studies to examine whether acceleration of disease progression also occurs in humans with
appreciable steatosis who undergo a partial hepatectomy are therefor warranted. Currently,
few therapies are available to prevent the progression of NAFLD [1]. The prominent role of
oxidative stress in NAFLD pathogenesis has prompted the use of antioxidants, particularly
vitamin E, as an effective therapy in patients with progressive phenotypes of NAFLD. It has
been reported that vitamin E improves all the histological features of NAFLD (except for fibro-
sis) and decreases the NAFLD activity score when compared with placebo [25,26]. We also
showed in the present study, that vitamin E is a beneficial therapy to reduce the level of oxida-
tive stress after partial hepatectomy and to prevent the progression of NAFLD. Would our
findings be confirmed in humans, it may be of interest to examine whether patients with simple
steatosis benefit from interventions such as vitamin E administration after partial
hepatectomy.
In summary, our findings indicated that despite the intact regenerative capacity of mild
steatotic livers, these livers are predisposed to advance to a more progressive inflammatory
phenotype of NAFLD after partial hepatectomy. In addition, oxidative stress plays a pivotal
role in disease progression and vitamin E may be a beneficial therapy in preventing the advance
of steatosis to steatohepatitis after hepatic resection.
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